Kingswood Wealth Advisors LLC Lowers Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Kingswood Wealth Advisors LLC cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 31.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,925 shares of the pharmacy operator’s stock after selling 8,280 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in Walgreens Boots Alliance were worth $389,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Sound Income Strategies LLC grew its stake in shares of Walgreens Boots Alliance by 9.1% in the first quarter. Sound Income Strategies LLC now owns 434,476 shares of the pharmacy operator’s stock worth $9,424,000 after acquiring an additional 36,106 shares during the last quarter. Kwmg LLC increased its stake in Walgreens Boots Alliance by 8.8% during the 1st quarter. Kwmg LLC now owns 331,779 shares of the pharmacy operator’s stock valued at $7,196,000 after purchasing an additional 26,932 shares in the last quarter. Thompson Investment Management Inc. raised its holdings in Walgreens Boots Alliance by 1.1% in the first quarter. Thompson Investment Management Inc. now owns 505,150 shares of the pharmacy operator’s stock worth $10,957,000 after buying an additional 5,267 shares during the last quarter. Riverview Trust Co purchased a new stake in shares of Walgreens Boots Alliance during the first quarter valued at approximately $70,000. Finally, Gateway Investment Advisers LLC increased its position in shares of Walgreens Boots Alliance by 81.9% during the first quarter. Gateway Investment Advisers LLC now owns 14,024 shares of the pharmacy operator’s stock valued at $304,000 after acquiring an additional 6,315 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

WBA has been the topic of several recent analyst reports. Barclays cut their target price on Walgreens Boots Alliance from $21.00 to $19.00 and set an “underweight” rating on the stock in a research note on Monday. Bank of America reduced their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a report on Tuesday, March 26th. Evercore ISI lowered their target price on shares of Walgreens Boots Alliance from $18.00 to $17.00 and set an “in-line” rating on the stock in a research note on Monday, June 3rd. Morgan Stanley reduced their price target on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating for the company in a research note on Friday, May 31st. Finally, SVB Leerink lowered their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating on the stock in a research report on Monday, March 18th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $23.07.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of the stock in a transaction that occurred on Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Manmohan Mahajan acquired 6,000 shares of the business’s stock in a transaction dated Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a filing with the SEC, which is available through this link. Also, Director Inderpal S. Bhandari bought 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by company insiders.

Walgreens Boots Alliance Trading Down 22.2 %

NASDAQ WBA opened at $12.19 on Friday. The stock’s 50-day moving average price is $16.72 and its 200-day moving average price is $20.33. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance, Inc. has a 52 week low of $11.68 and a 52 week high of $31.32.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.16 earnings per share. Equities research analysts predict that Walgreens Boots Alliance, Inc. will post 3.21 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 8.20%. The ex-dividend date of this dividend was Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio is currently -14.29%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.